Growth Investing

Gold is on the march. The yellow metal is spiking to a new all time (non inflation-adjusted) highs... Read More

Gold is on the march. The yellow metal is spiking to a new all time (non inflation-adjusted) highs of nearly $1,300 per ounce on renewed speculation that the Federal Reserve’s next moves will... Read More

Investing in China has not been for the faint of heart. Shares of major companies have surged and fallen in repeating cycles during the past few years. But take a step back and note that China’s economic growth has only been going one way… Read More

Large pharmaceutical companies have been ignored by investors for some time now. After decades of gangbuster growth and blockbuster drugs to treat depression, high blood pressure and many other common ailments, many are facing competition from generic drugs as the patents protecting the exclusive… Read More

A seldom mentioned emerging market country is nurturing a future oil giant. Few are aware that Colombia is a growing and dynamic economy. Many people think of Colombia as a violent and lawless place dominated by drug cartels, or perhaps even… Read More

The banking industry still has a rocky road ahead of it as it struggles to shake the hangover headache from the financial meltdown that tipped the U.S. economy into recession. A quick check of the Federal Deposit Insurance Corp.’s website paints… Read More

I attended an investment conference last week and listened to a number of business updates from leading financial institutions. The vast majority are staying extremely conservative with their lending activities and are waiting for more tangible signs of an economic recovery before they start shifting gears from surviving the credit… Read More

A clear trend has emerged in the health care sector. Large companies are having an awfully hard time finding ways to grow. As an example, I recently took a look at the dimming outlook for industry giant Medtronic (NYSE: MDT). [Read more.] In that column, I added… Read More